Dimension Therapeutics, Inc.
DelistedCIK 1592288fmd_15XZTJQGRC247DJNPXZX9W4SSPManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2013 to Sep 30, 2017, 16 periods
| Line item | FY2014 | FY2015 | FY2016 |
|---|---|---|---|
| Total revenues | 3 | 8 | 11 |
| Research and development | 13 | 34 | 48 |
| Total operating expenses | 16 | 43 | 61 |
| Operating income | (13) | (35) | (49) |
| Income tax expense | 0 | 0 | 0 |
| Net income | (13) | (35) | (49) |
| Net income to common shareholders | (13) | (35) | (49) |